Edwards Lifesciences Trade and Non Trade Receivables Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 134.32  0.50  0.37%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Trade and Non Trade Receivables of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Total Assets representing trade and non-trade receivables.
Trade and Non Trade Receivables  10 Years Trend  
Increasing
Slightly volatile
 Trade and Non Trade Receivables 
      Timeline 

Edwards Lifesciences Trade and Non Trade Receivables Over Time

2016-12-31  414,600,000 
2017-12-31  414,600,000 
2018-12-31  413,894,737 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  308,376,518
Geometric Mean  286,887,108
Coefficient Of Variation  33.04
Mean Deviation  79,489,629
Median  335,300,000
Standard Deviation  101,891,361
Range  314,000,000
R Value  0.93
R Squared  0.86
Significance  0.00000538
Slope  24,239,387

Currently Trending

INGN   
 NMS 
Purchased few shares of
few hours ago ago
Traded for 124.46
CMTL   
 NMS 
Purchased over 20 shares of
few hours ago ago
Traded for 21.88
IPGP   
 NMS 
Purchased few shares of
few hours ago ago
Traded for 239.36